Literature DB >> 16254113

Grading melanocytic dysplasia in paraffin wax embedded tissue by the nucleic acid index.

D M Berman1, S Wincovitch, S Garfield, M J Romeo.   

Abstract

BACKGROUND: Although nucleic acid derangements are the hallmark of melanocytic dysplasia, the gold standard for its diagnosis remains the microscopic evaluation of haematoxylin and eosin stained slides. However, light microscopy is subjective and crucial genomic changes do not always show as changes in histology. AIMS: To introduce the nucleic acid index (NAI) as a means of analysing nucleic acid derangements in histological sections at the level of the individual cell and within the context of its microenvironment.
METHODS: Confocal laser scanning microscopy was performed on melanocytic lesions stained with acridine orange (AO), a fluorescent stain for DNA and RNA. The NAI, calculated by measuring the fluorescence intensities of AO in nuclei relative to the surrounding cytoplasm, reflects the concentration of DNA relative to RNA.
RESULTS: When applied to benign naevi, dysplastic naevi, and melanoma, a very strong significant association was seen between lower NAI and malignant potential (p < 0.0001). Strong inverse correlations were found between NAI and both mitotic index and Breslow thickness. Interestingly, the NAI for dysplastic naevi is between that of melanoma and most benign naevi, consistent with their intermediate biological behaviour and histological appearance.
CONCLUSION: By providing a quantitative measure for melanocytic neoplasia, the NAI may improve the diagnosis of melanocytic lesions and the selection of treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16254113      PMCID: PMC1770753          DOI: 10.1136/jcp.2005.026559

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  26 in total

1.  BRAF mutations are common somatic events in melanocytic nevi.

Authors:  Rajiv Kumar; Sabrina Angelini; Erna Snellman; Kari Hemminki
Journal:  J Invest Dermatol       Date:  2004-02       Impact factor: 8.551

2.  RNA sequestration to pathological lesions of neurodegenerative diseases.

Authors:  S D Ginsberg; J E Galvin; T S Chiu; V M Lee; E Masliah; J Q Trojanowski
Journal:  Acta Neuropathol       Date:  1998-11       Impact factor: 17.088

3.  Argyrophilic staining of nucleolar organizer region count and morphometry in benign and malignant melanocytic lesions.

Authors:  Ling-Xi L Li; Kerry A Crotty; Allan A Palmer; Jillian J Kril; Richard A Scolyer; John F Thompson; Stanley W McCarthy
Journal:  Am J Dermatopathol       Date:  2003-06       Impact factor: 1.533

Review 4.  Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer.

Authors:  Boris C Bastian
Journal:  Oncogene       Date:  2003-05-19       Impact factor: 9.867

5.  High frequency of BRAF mutations in nevi.

Authors:  Pamela M Pollock; Ursula L Harper; Katherine S Hansen; Laura M Yudt; Mitchell Stark; Christiane M Robbins; Tracy Y Moses; Galen Hostetter; Urs Wagner; John Kakareka; Ghadi Salem; Tom Pohida; Peter Heenan; Paul Duray; Olli Kallioniemi; Nicholas K Hayward; Jeffrey M Trent; Paul S Meltzer
Journal:  Nat Genet       Date:  2002-11-25       Impact factor: 38.330

Review 6.  Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma.

Authors:  M B Lens; M Dawes
Journal:  Br J Dermatol       Date:  2004-02       Impact factor: 9.302

7.  Discrimination of benign common nevi from malignant melanoma lesions by use of features based on spectral properties of the wavelet transform.

Authors:  Marco Wiltgen; Armin Gerger; Christian Wagner; Patrick Bergthaler; Josef Smolle
Journal:  Anal Quant Cytol Histol       Date:  2003-10       Impact factor: 0.302

8.  Grading of atypia in nevi: correlation with melanoma risk.

Authors:  Montserrat Arumi-Uria; N Scott McNutt; Bridget Finnerty
Journal:  Mod Pathol       Date:  2003-08       Impact factor: 7.842

9.  Bivariate RNA and DNA content analysis in breast carcinoma: biological significance of RNA content.

Authors:  A K El-Naggar; B L Kemp; N Sneige; K G Hurr; K Steck; Z N Tu; H A Fritsche; S E Singletary; C M Balch
Journal:  Clin Cancer Res       Date:  1996-02       Impact factor: 12.531

10.  Use of multiple cytometric markers improves discrimination between benign and malignant melanocytic lesions: a study of DNA microdensitometry, karyometry, argyrophilic staining of nucleolar organizer regions and MIB1-Ki67 immunoreactivity.

Authors:  Ling-Xi L Li; Kerry A Crotty; Richard A Scolyer; John F Thompson; Jillian J Kril; Allan A Palmer; Stanley W McCarthy
Journal:  Melanoma Res       Date:  2003-12       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.